key: cord-0757859-g0j2u2l2 authors: nan title: Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score date: 2021-07-06 journal: Br J Surg DOI: 10.1093/bjs/znab183 sha: f0ab71ae23ee945eff717fc44290321a602337dd doc_id: 757859 cord_uid: g0j2u2l2 To support the global restart of elective surgery, data from an international prospective cohort study of 8492 patients (69 countries) was analysed using artificial intelligence (machine learning techniques) to develop a predictive score for mortality in surgical patients with SARS-CoV-2. We found that patient rather than operation factors were the best predictors and used these to create the COVIDsurg Mortality Score (https://covidsurgrisk.app). Our data demonstrates that it is safe to restart a wide range of surgical services for selected patients. Since the beginning of the COVID-19 pandemic tens of millions of operations have been cancelled 1 as a result of excessive postoperative pulmonary complications (51.2 per cent) and mortality rates (23.8 per cent) in patients with perioperative SARS-CoV-2 infection 2 . There is an urgent need to restart surgery safely in order to minimize the impact of untreated non-communicable disease. As rates of SARS-CoV-2 infection in elective surgery patients range from 1-9 per cent [3] [4] [5] [6] [7] [8] , vaccination is expected to take years to implement globally 9 and preoperative screening is likely to lead to increasing numbers of SARS-CoV-2-positive patients, perioperative SARS-CoV-2 infection will remain a challenge for the foreseeable future. In order to inform consent and shared decision making, a robust, globally applicable score is needed to predict individualized mortality risk for patients with perioperative SARS-CoV-2 infection. The authors aimed to develop and validate a machine learning-based risk score to predict postoperative mortality risk in patients with perioperative SARS-CoV-2 infection. An international, multicentre, prospective, cohort study (COVIDsurg Cohort Study) included consecutive patients who were diagnosed with SARS-CoV-2 in the 7 days before or the 30 days after surgery. Patients undergoing any type of surgery were included from 1 February 2020 to 31 July 2020. Full study methodology has been published previously 2 . Machine learning methods were used to analyse the COVIDsurg Cohort Study dataset. Sixteen patient and operative variables were entered into the analysis and, based on time, data were split into a derivation set, where all analysis and modelling were performed, and a validation set, where the final model was assessed. Five features were selected following variable importance measurements from both linear and non-linear modelling. These features were then combined into 26 different predictor sets, which were fitted through three different algorithms (logistic regression, decision trees and random forest), generating a total of 78 different models. These models were tuned with a 10-fold cross-validation, fitted in the 75 per cent split of the derivation set and assessed in the remaining 25 per cent. In order to ascertain the model's stability, this training and testing split was randomly repeated 100 times (bootstraps). Finally, to decide which model to select, performance was evaluated through the mean area under the receiver operating characteristic curve (AUROC) value. A full description of methods is available in Appendix S1. From 10 029 patients in the cohort study, data from 8492 patients entered the machine learning processes (Fig. 1) . The most common surgical procedures were abdominal (40.6 per cent, 3446 of 8492 patients), orthopaedic (33.8 per cent, 2867 of 8492) and head and neck surgery (9.8 per cent, 835 of 8492). Emergency surgery accounted for 80.8 per cent (6862 of 8492 patients) and benign disease for 57.3 per cent (4868 of 8492) ( Table S1) . Of the 8492 patients, data from 6777 patients who had surgery from February to May 2020 (726 hospitals, 65 countries) were entered into the derivation set and data from 1715 who had surgery from June to July 2020 (296 hospitals, 53 countries) were entered into the validation set. Despite changes in patient demographics and treatment options, such as the recommendations from the RECOVERY trial 10 in June 2020, model performance remained robust between the derivation and validation sets. Mortality rates were 17.2 per cent overall (1462 of 8492 patients), 18.9 per cent (1279 of 6777) in the derivation set and 10.7 per cent (183 of 1715) in the validation set. Missing data handling is described in Appendix S2. A full breakdown of feature and model selection are in Tables S3-S7 . Random forest and elastic net were applied to the derivation set and the most important features were ranked (Fig. S1) . Logit model performance of all different feature combination (runs) divided by each of the features is shown in Fig. 2a . The five features taken forward into model building were age, preoperative respiratory support, ASA grade, specialty and revised cardiac risk index (RCRI) score. Multivariable models were built using all possible combinations of the five selected features, resulting in 26 model runs ( Table S8) . The smallest, higher-performing and most robust model was a logistic regression model with four features (age, ASA grade, RCRI score and preoperative respiratory support). A full description is in Appendix S2. The AUROC for the final score was 0.73 (95 per cent c.i. 0.71 to 0.74) in the derivation set and 0.80 (95 per cent c.i. 0.77 to 0.83) in the validation set (Fig. 2b) . Calibration in the validation set is shown in Fig. S2 (Brier score 0.084, intercept 0.078, slope 1.08). Mortality rates were studied for different probability risk cutoffs (Fig. S3) , with a balance between distribution and clinical importance leading to cut-off values at approximately 2, 10, 30 and 45 per cent mortality. These showed high concordance between derivation and validation sets (Supplementary Table S7) with the final mortality percentages in the combined dataset being very similar. The COVIDSurg Mortality Score has been deployed online at http://covidsurgrisk.app/. Understanding risks related to SARS-CoV-2 and COVID-19 will remain important for the foreseeable future. There is an urgent need to restart elective surgery in order to reduce the backlog of cancelled operations 11 . Vaccination programmes are expected to take years to deliver, particularly in low-and middle-income countries 9 , and may not protect against new variants 12 . COVID-19-free surgical pathways are unlikely to be universally implemented, particularly in emergency settings 3 , leaving patients at risk of in-hospital SARS-CoV-2 transmission. Research is critical to mitigate impact. The COVIDsurg Morality Score is a tool that can help overcome these challenges and has clear clinical applications. It can inform consent and shared decision making by patients and surgeons. If individual patient mortality risk is too high, they may choose to postpone surgery. If surgery is unavoidable, risks should be clearly documented as part of informed consent, and postoperative critical care can be identified and justified. It can also identify patients who are at very low risk, where surgery can continue as planned. The COVIDSurg Mortality Score shows high discrimination for predicting mortality in patients with perioperative SARS-CoV-2. The AUROCs in the derivation (0.73) and validation (0.80) sets are consistent with published non-surgical COVID risk scores 13 . The COVIDSurg Mortality Score is globally applicable and consists of variables that are readily available across all resource settings. The score was derived and validated in a global data set (all types of surgery, 756 hospitals, 69 countries) and demonstrated validity across geographic regions and over time as community SARS-CoV-2 infection rates fluctuated. The COVIDSurg cohort study was prospectively collected and conducted, but it had limitations. Variables were coded following standardized medical criteria but a further analysis of continuous variables as well as the inclusion of interactions 14 could be incorporated in future studies. As there are no other international, multispecialty data sets for SARS-CoV-2 surgical patients, further external validation was not possible, but should be considered if such data sets emerge. High mortality percentages (approximately 47 per cent) at higher probability outputs (greater than 0.5) should be interpreted with caution, as numbers of patients with these feature combinations were low. The authors acknowledge that the model will warrant updates as more data become available. Despite differences in mortality between the derivation and validation sets, model performance remained robust. There are likely to have been structural and system differences between hospitals that were not captured in the cohort study. These differences are further compounded by variation in community SARS-CoV-2 across time and across geographical locations. Nonetheless, the score performed well in the validation set, suggesting the score can be used reliably both during COVID waves and troughs. Hospital Sotero Del Rio Fundacion Cardioinfantil-Instituto de Cardiología Baheya Centre for Early Detection and Treatment of Breast Cancer Kafr El Zayyat Hospital Lä nsi-Pohja Central Hospital Hô pital Louis-Mourier AP-HP Klinikum Saarbrü cken Athens Naval and Veterans Hospital Echeverría-Dá vila (Hospital General Icaza de Marín* (Hospital Regional De Zacapa Rotunda Hospital Ospedale Maggiore/Bellaria Carlo Alberto Pizzardi Ausl Bologna Sant'orsola Hospital Ospedale per gli Infermi di Faenza Vito Fazzi' Hospital A. Gianni' (Fondazione IRCSS Ca' Granda-Ospedale Maggiore Policlinico Ospedale San Filippo Neri Sant'Eugenio Hospital San Carlo Borromeo Hospital IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella Zawia Teaching Hospital Herná ndez Miguelena (Hospital Regional Veracruz Van den den Broek Federal Teaching Hospital The Children's Hospital & The Institute of Child Health Lahore Bukhari* (Lady Reading Hospital Hospital De Especialidades Pediatricas CSS Hospital Irma De Lourdes Tzanetatos CSS Hospital Hermilio Valdizan Medrano Hospital Nacional Daniel Alcides Carrió n Huamá n* (Hospital Guillermo Kaelin de la Fuente Huamá n Egoá vil (Hospital Emergencia Ate Vitarte Curvas (Hospital de Braganc¸a Deus (Hospital Do Litoral Alentejano Clinica Chirurgie I, Spitalul Clinic Judetean de Urgenta Clinic of Coloproctology and Minimally Invasive Surgery King Fahad Hospital Hofuf Al Ayed (King Salman Armed Forces Hospital Jimé nez Jimé nez Yepes Cano* (Hospital Universitario De Gran Canaria Doctor Negrín Sá nchez* (Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria García Pé rez (Hospital Mateu Orfila García Fló rez* (Hospital Universitario Central De Asturias (Huca) Sangü esa (Hospital Arnau De Vilanova Ferná ndez Martín* (Hospital Medina Del Campo Pourtales Neuchâ tel Hospital Gö ksoy* (Sehit Prof. Dr _ Ilhan Varank Training and Research Hospital A. Kocatas (Kanuni Sultan Suleyman Training and Research Hospital Samsun Training and Research Hospital Al Jalila Children's Speciality Hospital Latifa Women and Children Hospital Antrim Area Hospital, Northern Health and Social Care Trust Birmingham Children's Hospital A. Durrani (Addenbrooke's Hospital Lancashire Teaching Hospitals NHS Foundation Trust Russell's Hall Hospital The Walton Centre NHS Foundation Trust Alder Hey In The Park Evelina London Children's Hospital Stamenkovic (Cardiac Unit St Bartholomew's Hospital Smart* (Macclesfield District General Hospital Hormis* (Rotherham District General Hospital Sheffield Teaching Hospital NHS Foundation Trust Bakolas, I. Ahmed* (Good Hope Hospital Sapre (King's Mill Hospital Worcestershire Acute Hospitals NHS Trust Colling* (Saint Mary's Medical Center-Essentia Health Le Bonheur Children's Hospital Froedtert Hospital Seattle Children's Hospital Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an International, Multicenter, Comparative Cohort Study Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic Surgery and COVID-19 COVID-19 NOC Surgical Team. 30-day outcome after orthopaedic surgery in patients assessed as negative for COVID-19 at the time of surgery during the peak of the pandemic Nosocomial infection with SARS-CoV-2 and main outcomes after surgery within an orthopaedic surgery department in a tertiary trauma centre in Spain Surgery and COVID-19: balancing the nosocomial risk: a French academic centre experience during the epidemic peak Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis Resource requirements for reintroducing elective surgery during the COVID-19 pandemic: modelling study Preparing for a COVID-19 resurgence in the WHO African region Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study Data sharing requests will be considered by the management group upon written request to the corresponding author. Step 4 Step 1: Specify your systematic review question(s) -not applicable.Step 2: Classify the type of prediction model evaluation -development and validation.Step 3 Supplementary material is available at BJS online.